Zimmer Biomet shares are trading lower. The company announced it will purchase the iovera cryoeurolysis pain relief device from Pacira BioSc

Zimmer Biomet shares are trading lower. The company announced it will purchase the iovera cryoeurolysis pain relief device from Pacira BioSciences for up to $140 million.